Generic drug development past the ANDA filing date is where most companies either build durable competitive moats or bleed out […]
Post-ANDA Patent Strategy: The Complete Playbook for Generic Market Domination Read Post »
Introduction: Generic Drugs as the Core Economic Infrastructure of Global Healthcare Scale, Dominance, and the Savings Calculus Generic drugs now
The Global Generic Drug Market: Trends, Opportunities, and Challenges Read Post »
1. Executive Summary and Scope Generic drugs fill 91% of all U.S. prescriptions and generated an estimated $2.44 trillion in
1. Why Cost Structure Is Your Only Durable Weapon The global generic drug market reached approximately $491 billion in 2024.
Section 1: The Affordability Paradox: Why the Generic Market Rewards Complexity, Not Cost The generic drug industry has an identity
Generic Drug Market Strategy: The Complete Competitive Playbook Read Post »
1. The CDMO Market: Size, Consolidation, and the IP Stakes That Changed Everything The global contract development and manufacturing organization
A technical deep dive for IP teams, portfolio managers, R&D leads, and institutional investors in biologics and biosimilar development. Why
Biosimilar Regulatory Strategy: The Complete Playbook for FDA, EMA, and Global Approval Read Post »
A single drug can generate $10 billion in annual revenue. The same drug, one day after its last relevant patent
“The average branded drug loses roughly 80% of its revenue within 12 months of generic entry. What happens in the
Drug Patent Expirations: The $236 Billion Investment Playbook Read Post »
Get fresh news and insights, drug patent expirations & more…
